Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LCAV

LCA-Vision (LCAV) Stock Price, News & Analysis

About LCA-Vision Stock (NASDAQ:LCAV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

LCA-Vision Inc. is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. The Company's vision centers provide the staff, facilities, equipment and support services for performing laser vision correction that employ advanced laser technologies to help correct nearsightedness, farsightedness and astigmatism. The Company's vision centers are supported by independent, ophthalmologists and credentialed optometrists, as well as other healthcare professionals. The ophthalmologists perform the laser vision correction procedures in the Company's vision centers, and ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-up care in-center. Most of the Company's patients receive a procedure called laser-assisted in situ keratomileusis (LASIK). As of December 31, 2011, it had performed over 1.2 million laser vision correction procedures in its vision centers in the United States and Canada.

Receive LCAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LCA-Vision and its competitors with MarketBeat's FREE daily newsletter.

LCAV Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
LCAV Historical Data
Apple Vision Pro
See More Headlines

LCAV Stock Analysis - Frequently Asked Questions

LCA-Vision Inc. (NASDAQ:LCAV) announced its quarterly earnings data on Wednesday, April, 30th. The healthcare company reported ($0.01) EPS for the quarter, missing analysts' consensus estimates of $0.23 by $0.24. The healthcare company had revenue of $25.53 million for the quarter, compared to the consensus estimate of $32.04 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that LCA-Vision investors own include Gen Digital (GEN), Amyris (AMRS), American Superconductor (AMSC), Digital Turbine (APPS), Athersys (ATHX), AVEO Pharmaceuticals (AVEO) and Bloom Energy (BE).

Company Calendar

Last Earnings
4/30/2014
Today
6/18/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:LCAV
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:LCAV) was last updated on 6/19/2025 by MarketBeat.com Staff
From Our Partners